[1] HEO Y A. Imipenem/cilastatin/relebactam: a review in gram-negative bacterial infections[J]. Drugs, 2021, 81(3): 377-388. [2] 郭玲, 罗雪梅, 梁培, 等. 高效液相色谱法测定重症患者亚胺培南血药浓度及PK/PD达标率研究[J]. 中国医院药学杂志, 2017, 37(16): 1598-1601. [3] 郭玲, 罗雪梅, 梁培, 等. 重症患者亚胺培南血药浓度监测结果的相关因素分析[J]. 药学与临床研究,2017,25(6):489-492. [4] ROBERTS J A, PAUL S K, AKOVA M, et al. DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?[J]. Clin Infect Dis, 2014,58(8):1072-1083. [5] 徐硕, 金鹏飞, 徐文峰, 等. 碳青霉烯类药物亚胺培南血药质量浓度测定方法的研究进展[J]. 西北药学杂志,2020,35(3):467-470. [6] 董玲芳, 段虹飞, 张海峰, 等. 亚胺培南血药浓度测定方法改进及其在血浆中稳定性考察[J]. 中国医院药学杂志,2015,35(1):6-9. [7] KEEL R A, SUTHERLAND C A, CRANDON J L, et al. Stability of doripenem, imipenem and meropenem at elevated room temperatures[J]. Int J Antimicrob Agents, 2011,37(2):184-185. [8] 刘浩, 王红武, 仇仕林. 碳青霉烯类抗生素的高效液相色谱峰形研究Ⅱ.亚胺培南色谱峰的展宽和裂分[J]. 中国抗生素杂志,2003(8):468-471,474. [9] LEFEUVRE S, BOIS-MAUBLANC J, HOCQUELOUX L, et al. A simple ultra-high-performance liquid chromatography-high resolution mass spectrometry assay for the simultaneous quantification of 15 antibiotics in plasma[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2017(1065-1066):50-58. [10] VERDIER M C, TRIBUT O, TATTEVIN P, et al. Simultaneous determination of 12 beta-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: application to therapeutic drug monitoring[J]. Antimicrob Agents Chemother, 2011,55(10):4873-4879. [11] 彭洁, 洪建文, 陈冬妮. 高效液相色谱法测定亚胺培南的有关物质[J]. 今日药学,2013,23(11):733-735. [12] LEGRAND T, CHHUN S, REY E, et al. Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2008,875(2):551-556. [13] 郭楠, 詹莹, 邵华, 等. 高效液相色谱法测定重症患者的亚胺培南血药浓度[J]. 中国临床药理学杂志,2015,31(8):645-647. [14] 温爱萍, 李哲, 李任, 等. HPLC法测定人血浆中游离亚胺培南浓度[J]. 中国药物应用与监测,2015,12(3):151-154. [15] 邓阳, 徐兵, 李昕, 等. 基于亚胺培南稳定性考察的治疗药物监测临床采样流程建立[J]. 中国临床药理学杂志,2018,34(18):2207-2210. [16] 岑丽莲,陈雄毅,苏健尹.某院2016-2018年ICU多重耐药菌感染特点分析[J]. 现代医院,2020,20(2):277-279,282. |